Chile: The Strategic Choice for Global-Quality Clinical Execution
- Danica Mimica
- Oct 25
- 1 min read
Updated: Nov 18
Why Chile Continues to Attract Global Sponsors
Chile offers one of the most stable and efficient clinical research environments in LATAM — combining fast regulatory timelines, modern infrastructure, and motivated patient communities.
At PRS, we work hand-in-hand with experienced Chilean investigators, top-performing sites, and accredited institutions. They are not only ICH/GCP-compliant and internationally trained but also fully aligned with evolving global standards and innovations across key therapeutic areas such as oncology, neuroscience, and rare diseases.
With a strong track record in global trials and a collaborative approach, Chile stands out as a smart choice for sponsors seeking quality, speed, and reliability in the region.
If your team is exploring Chile and Latin America, we’re happy to share what’s worked — and what to avoid. Follow us on:
Comments